{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:47Z","timestamp":1790838587736,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Experts recommend postpartum oxytocin to prevent uterine atony and hemorrhage, but oxytocin may be associated with dose-dependent adverse effects, and the correct dose of postpartum oxytocin has yet to be determined. The effective dose in 90% of patients (ED90) of oxytocin after cesarean delivery may be higher in patients exposed to oxytocin during labor compared to patients unexposed. We therefore undertook this study to compare postpartum oxytocin requirements in patients exposed to oxytocin prior to cesarean delivery versus those not exposed, when all were treated according to a specific institutional protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this retrospective chart review, we reviewed medical records of patients who underwent cesarean delivery under neuraxial anesthesia and noted demographic data, relevant comorbidities, and oxytocin exposure, infusion rate, and duration prior to delivery. Patients exposed to oxytocin before cesarean (OXY+ group) were compared to those not exposed (OXY\u2212 group). The primary outcome variable was highest infusion rate of postpartum oxytocin required per institutional protocol. Secondary outcomes included estimated blood loss, proportion of patients with postpartum hemorrhage, and proportions who received other uterotonic medications or red blood cell transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      OXY+ patients were more likely to be nulliparous and had higher estimated gestational age and neonatal weight than OXY\u2212 patients. They also had higher incidence of chorioamnionitis and lower incidence of multiple gestation. OXY+ patients required a high postpartum oxytocin infusion rate more often than OXY\u2212 patients (adjusted odds ratio 1.94 [95% confidence interval, 1.19\u20133.15;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .008]). They also received other uterotonic agents more commonly. Estimated blood loss, hemorrhage rates, and transfusion rates did not differ between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Reported increases in the ED90 of postpartum oxytocin after oxytocin exposure during labor appear to be clinically significant. We have therefore altered our institutional protocol so that women preexposed to oxytocin routinely receive higher initial postpartum oxytocin infusion rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000002401","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T12:20:33Z","timestamp":1504182033000},"page":"920-924","source":"Crossref","is-referenced-by-count":12,"title":["Patients Undergoing Cesarean Delivery After Exposure to Oxytocin During Labor Require Higher Postpartum Oxytocin Doses"],"prefix":"10.1213","volume":"126","author":[{"given":"Amanda","family":"Foley","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Critical Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Gunter","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Nunes","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Shahul","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Scavone","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care"},{"name":"Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(14)60696-6","article-title":"Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.","volume":"384","author":"Kassebaum","year":"2014","journal-title":"Lancet"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1054\/ijoa.2002.0970","article-title":"Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia.","volume":"11","author":"Pinder","year":"2002","journal-title":"Int J Obstet Anesth"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijoa.2008.03.003","article-title":"The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: findings in six cases.","volume":"17","author":"Archer","year":"2008","journal-title":"Int J Obstet Anesth"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/bja\/aen071","article-title":"Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during caesarean section.","volume":"100","author":"Svanstr\u00f6m","year":"2008","journal-title":"Br J Anaesth"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1471-0528.2009.02356.x","article-title":"ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial.","volume":"117","author":"Jonsson","year":"2010","journal-title":"BJOG"},{"key":"R7-20230721","first-page":"499","article-title":"Maternal deaths from anaesthesia. an extract from why mothers die 1997\u20131999, the confidential enquiries into maternal deaths in the United Kingdom.","volume":"89","author":"Thomas","year":"2002","journal-title":"Br J Anaesth"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/bja\/aen273","article-title":"Intravenous oxytocin bolus of 2 units is superior to 5 units during elective caesarean section.","volume":"101","author":"Sartain","year":"2008","journal-title":"Br J Anaesth"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/bja\/ael302","article-title":"Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing caesarean section.","volume":"98","author":"Thomas","year":"2007","journal-title":"Br J Anaesth"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.AOG.0000142709.04450.bd","article-title":"Oxytocin requirements at elective cesarean delivery: a dose-finding study.","volume":"104","author":"Carvalho","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.AOG.0000191529.52596.c0","article-title":"Minimum oxytocin dose requirement after cesarean delivery for labor arrest.","volume":"107","author":"Balki","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12630-010-9297-1","article-title":"Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing cesarean delivery.","volume":"57","author":"George","year":"2010","journal-title":"Can J Anaesth"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1213\/ANE.0000000000000781","article-title":"The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.","volume":"121","author":"Lavoie","year":"2015","journal-title":"Anesth Analg"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijoa.2013.03.007","article-title":"Outcomes after institution of a new oxytocin infusion protocol during the third stage of labor and immediate postpartum period.","volume":"22","author":"Dagraca","year":"2013","journal-title":"Int J Obstet Anesth"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/jrf.0.1200091","article-title":"Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour.","volume":"120","author":"Phaneuf","year":"2000","journal-title":"J Reprod Fertil"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/GRF.0b013e3181cc406d","article-title":"Postpartum hemorrhage: epidemiology, risk factors, and causes.","volume":"53","author":"Oyelese","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"56.e1","DOI":"10.1016\/j.ajog.2010.08.023","article-title":"Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony.","volume":"204","author":"Grotegut","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1213\/ANE.0b013e3181d74898","article-title":"The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries.","volume":"110","author":"Bateman","year":"2010","journal-title":"Anesth Analg"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1213\/01.ane.0000286233.48111.d8","article-title":"The accuracy of blood loss estimation after simulated vaginal delivery.","volume":"105","author":"Toledo","year":"2007","journal-title":"Anesth Analg"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1213\/ANE.0000000000001658","article-title":"Effect of a high-rate versus a low-rate oxytocin infusion for maintaining uterine contractility during elective cesarean delivery: a prospective randomized clinical trial.","volume":"124","author":"Duffield","year":"2017","journal-title":"Anesth Analg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201803000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:25:46Z","timestamp":1786112746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201803000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000002401","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}